Indication
Scalp psoriasis
Scalp psoriasis is a chronic, immune-mediated dermatologic manifestation of psoriasis that selectively affects the integumentary system of the scalp and often extends beyond the hairline to the forehead, retroauricular regions, and posterior neck. Read more about Scalp psoriasis
762 drugs 195 manufacturers
Drugs that treat it
Common Scalp psoriasis therapies.
CLOCORTOLONE PIVALATE
DESONIDE
DESOXIMETASONE
DIFLORASONE DIACETATE
FLUOCINOLONE ACETONIDE
FLUOCINONIDE
FLUOCINONIDE-E (fluocinonide/emollient base)
HYDROCORTISONE
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonScalp psoriasis is a chronic, immune-mediated dermatologic manifestation of psoriasis that selectively affects the integumentary system of the scalp and often extends beyond the hairline to the forehead, retroauricular regions, and posterior neck.
It can occur as an isolated condition or as part of generalized plaque psoriasis, driven pathophysiologically by dysregulated T-cell signaling and sustained proinflammatory cytokine cascades that accelerate epidermal keratinocyte proliferation.
Clinically, it is characterized by well-demarcated, erythematous or violaceous plaques covered with thick, silvery-white or micaceous scale, frequently accompanied by pruritus, burning, soreness, and shedding that can occasionally result in secondary, temporary telogen hair loss.
- psoriasis.org
Scalp psoriasis is a chronic, immune-mediated dermatologic manifestation of psoriasis that selectively affects the integumentary system of the scalp and often extends beyond the hairline to the forehead, retroauricular regions, and posterior neck
- forefrontdermatology.com
Scalp psoriasis is a chronic, immune-mediated dermatologic manifestation of psoriasis that selectively affects the integumentary system of the scalp and often extends beyond the hairline to the forehead, retroauricular regions, and posterior neck It can occur as an isolated condition or as part of generalized plaque psoriasis, driven pathophysiologically by dysregulated T-cell signaling and sustained proinflammatory cytokine cascades that accelerate epidermal keratinocyte proliferation
- nih.gov
It can occur as an isolated condition or as part of generalized plaque psoriasis, driven pathophysiologically by dysregulated T-cell signaling and sustained proinflammatory cytokine cascades that accelerate epidermal keratinocyte proliferation
- nih.gov
Clinically, it is characterized by well-demarcated, erythematous or violaceous plaques covered with thick, silvery-white or micaceous scale, frequently accompanied by pruritus, burning, soreness, and shedding that can occasionally result in secondary, temporary telogen hair loss
- dermnetnz.org
Clinically, it is characterized by well-demarcated, erythematous or violaceous plaques covered with thick, silvery-white or micaceous scale, frequently accompanied by pruritus, burning, soreness, and shedding that can occasionally result in secondary, temporary telogen hair loss
- uclahealth.org
Clinically, it is characterized by well-demarcated, erythematous or violaceous plaques covered with thick, silvery-white or micaceous scale, frequently accompanied by pruritus, burning, soreness, and shedding that can occasionally result in secondary, temporary telogen hair loss
- jddonline.com
Clinically, it is characterized by well-demarcated, erythematous or violaceous plaques covered with thick, silvery-white or micaceous scale, frequently accompanied by pruritus, burning, soreness, and shedding that can occasionally result in secondary, temporary telogen hair loss
Personalize your experience
Follow Scalp psoriasis and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.